Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
Dieter Riemann, PhD
JCP
Letter to the Editor
Aggravation of Suicide Risk With Daridorexant: Currently Not Enough Data to Show a Link
July 3, 2023
Palagini and colleagues comment on a recent letter that suggested a role for daridorexant, a new hypnotic, in increasing suicide risk.
Laura Palagini
,
Pierre A. Geoffroy
,
Jean Arthur Micoulaud-Franchi
, et al
JCP
Original Research
Impact of Sleep-Related Complaints on Depressive Symptoms in Patients With Restless Legs Syndrome
September 15, 2005
Magdolna Hornyak
,
Marta Kopasz
,
Mathias Berger
, et al
JCP
Original Research
Doxepin in the Treatment of Primary Insomnia: A Placebo-Controlled, Double-Blind, Polysomnographic Study
June 1, 2001
Göran Hajak
,
Andrea Rodenbeck
,
Ulrich Voderholzer
, et al
